Guiomar Martín-Lozano1, Raquel Gómez-Díaz2, Fernando Iglesías-Martín1, Daniel Torres-Lagares3, Aida Gutiérrez-Corrales4, José-Luis Gutiérrez-Pérez5. 1. Oral and Maxillofacial Surgery Unit, Virgen del Rocío University Hospital, Seville, Spain. 2. Instituto de Biomedicina de Sevilla, Seville, Spain. 3. Full Professor of Oral Surgery at Dental School. University of Sevilla, Seville, Spain. 4. Oral Surgery Department, Dentistry Faculty, University of Seville, Seville, Spain. 5. Oral and Maxillofacial Unit, Virgen del Rocio Hospital, Seville, Spain. Oral Surgery Department, Dentistry Faculty, University of Seville, Seville, Spain.
Abstract
BACKGROUND: Cancer is a genetic disease caused by mutations in DNA and epigenetic alterations that control gene expression. The majority of epidermoid carcinomas develop within the fields of epithelial genetic alterations. The mechanisms underlying tumorigenesis of epidermoid carcinoma are as yet unknown; therefore, precise identification of the risk factors is needed. Aim: The main aim of this study is to analyse and identify the emergence of the mutations described in the literature of the p53 gene with regard to the emergence of cancer in a sample of dysplastic and cancerous lesions in oral cavity mucosa in the population of the south of Spain, in order to determine the presence of said mutations and the percentage of them in our population. MATERIAL AND METHODS: A cross-sectional study was carried out, with a sample size of 22 patients with potentially malignant oral lesions ancillary to biopsy. All were patients, of both sexes, over 18 years of age from the Virgen del Rocío University Hospital with potentially malignant lesions in oral mucosa ancillary to biopsy (leukoplakias, erythroplasias or leukoerythopkias). An anatomopathological study was performed on all the samples and the lesions were divided into three types: low-grade dysplasia, high-grade dysplasia and squamous cell carcinoma. In respect of the genome study process, a complete search or scan for mutations in exons 5, 6, 8 and 9 of the p 53 gene was carried out, given that in the IARC database we observed that the 5 and 6 as well as the 8 and 9 exon sizes can be scanned completely in this way, since they have amplificon sizes of 476 and 445 base pairs respectively. RESULTS: In the scan for the complete exons 5, 6, 8 and 9 only a single result of interest was found to be described. In patient NBI 57 a change was observed in the TAT triplet by ATT of EXON 6, the change being of the T nucleotide by the A and in both directions both in Forward and Reverse. The exact location in the NCBI is GR Ch 37 p13 on chromosome 17, EXON 6 of the P53 gene and the change is in the C.613 T>A nucleotide; NM_000546. CONCLUSIONS: On reviewing this genetic variant in different scientific databases, such as ENSEMBL among others, in at least 6 different biocomputing tools it is described as a pathogen, therefore we can conclude that it is a pathogenic mutation for this case in particular. The rest of the mutations described in the literature on exons 5, 6, 8 and 9 of the p53 gene have not been found in our sample. Key words:Oral cancer, p53, Mutations, Exon. Copyright:
BACKGROUND: Cancer is a genetic disease caused by mutations in DNA and epigenetic alterations that control gene expression. The majority of epidermoid carcinomas develop within the fields of epithelial genetic alterations. The mechanisms underlying tumorigenesis of epidermoid carcinoma are as yet unknown; therefore, precise identification of the risk factors is needed. Aim: The main aim of this study is to analyse and identify the emergence of the mutations described in the literature of the p53 gene with regard to the emergence of cancer in a sample of dysplastic and cancerous lesions in oral cavity mucosa in the population of the south of Spain, in order to determine the presence of said mutations and the percentage of them in our population. MATERIAL AND METHODS: A cross-sectional study was carried out, with a sample size of 22 patients with potentially malignant oral lesions ancillary to biopsy. All were patients, of both sexes, over 18 years of age from the Virgen del Rocío University Hospital with potentially malignant lesions in oral mucosa ancillary to biopsy (leukoplakias, erythroplasias or leukoerythopkias). An anatomopathological study was performed on all the samples and the lesions were divided into three types: low-grade dysplasia, high-grade dysplasia and squamous cell carcinoma. In respect of the genome study process, a complete search or scan for mutations in exons 5, 6, 8 and 9 of the p 53 gene was carried out, given that in the IARC database we observed that the 5 and 6 as well as the 8 and 9 exon sizes can be scanned completely in this way, since they have amplificon sizes of 476 and 445 base pairs respectively. RESULTS: In the scan for the complete exons 5, 6, 8 and 9 only a single result of interest was found to be described. In patient NBI 57 a change was observed in the TAT triplet by ATT of EXON 6, the change being of the T nucleotide by the A and in both directions both in Forward and Reverse. The exact location in the NCBI is GR Ch 37 p13 on chromosome 17, EXON 6 of the P53 gene and the change is in the C.613 T>A nucleotide; NM_000546. CONCLUSIONS: On reviewing this genetic variant in different scientific databases, such as ENSEMBL among others, in at least 6 different biocomputing tools it is described as a pathogen, therefore we can conclude that it is a pathogenic mutation for this case in particular. The rest of the mutations described in the literature on exons 5, 6, 8 and 9 of the p53 gene have not been found in our sample. Key words:Oral cancer, p53, Mutations, Exon. Copyright:
Authors: A Peggy Graveland; Jantine F Bremmer; Michiel de Maaker; Arjen Brink; Paul Cobussen; Meindert Zwart; Boudewijn J M Braakhuis; Elisabeth Bloemena; Isaäc van der Waal; C René Leemans; Ruud H Brakenhoff Journal: Oral Oncol Date: 2013-10-09 Impact factor: 5.337
Authors: M W Ho; E A Field; J K Field; J M Risk; B P Rajlawat; S N Rogers; J C Steele; A Triantafyllou; J A Woolgar; D Lowe; R J Shaw Journal: Br J Oral Maxillofac Surg Date: 2013-04-16 Impact factor: 1.651
Authors: Maarten P Tabor; Viola M M van Houten; J Alain Kummer; Maria J W D Vosjan; Ronald Vlasblom; Gordon B Snow; C René Leemans; Boudewijn J M Braakhuis; Ruud H Brakenhoff Journal: Genes Chromosomes Cancer Date: 2002-02 Impact factor: 5.006
Authors: Gillian L Hall; Richard J Shaw; E Anne Field; Simon N Rogers; David N Sutton; Julia A Woolgar; Derek Lowe; Triantafillos Liloglou; John K Field; Janet M Risk Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-08 Impact factor: 4.254